SecureCHEK AI, a software-as-a-service (SaaS) provider for the pharmaceutical industry, has won four awards in the 2024 Pharmaceutical Technology Excellence Awards, in the Innovation, Marketing, Product Launches, and Diversity categories.
The Pharmaceutical Technology Excellence Awards celebrate the greatest achievements and innovations in the industry. Powered by the business intelligence of GlobalData, the program provides a platform to recognize the people and companies that are driving change in the pharmaceutical industry.
SecureCHEK AI is being recognized for utilizing artificial intelligence (AI) to improve marketing efficiencies in content creation and quality control, and for its progressive stance on gender diversity and the influential role of women in leadership positions.
Innovation Award for Content Compliance as Digital Compliance Explodes
In response to the unprecedented surge in digital content required for pharmaceutical marketing, SecureCHEK AI has created an AI-powered technology that enhances the speed and capacity for content development and Medical, Legal, and Regulatory (MLR) review.
The company’s solution is built for integration with content and digital management systems to amplify prescription drug companies’ investment in their trusted enterprise platforms (e.g., Aprimo and Veeva). Specifically, SecureCHEK AI automates the currently manual tasks needed for optimal performance prior to MLR Review — with the goal of positively impacting every brand’s bottom and top lines and overall resource management (more with less).
Case studies demonstrate the measurable impact of SecureCHEK AI’s solutions in multiple therapeutic categories, including rare disease, respiratory disease, oncology, and neurology.
Marketing Award for Streamlining Processes Pre-MLR Review
Creating and maintaining claims libraries
The creation and continuous updating of centralized claims libraries has been a significant hurdle for 75% of pharmaceutical companies, with the process being notoriously labor-intensive. It can take days to mine content from promotional assets to create a library. SecureCHEK AI absorbs already approved content from in-market pieces or credentialed third-party sources, structuring that data into Claims Libraries in just hours, which translates into substantial cost savings and a more streamlined review process.
In addition to boosting editorial productivity and efficiency, the SecureCHEK AI technology maximizes the use of current campaign assets that are easily mined to enable a more strategic deployment of marketing resources.
SecureCHEK AI claims libraries create a foundation for modular and personalized content at scale. The software uses automation to create, manage, store and check variations of content in a centralized repository as a reference point for content creation (via integration with ADOBE InDesign). This human + AI solution delivers on the mandate for highly personalized HCP and patient materials that has eluded marketers for years.
Validating content quality
Ninety-nine percent of companies are manually pre-checking content before MLR Review. SecureCHEK AI automates these pre-checks against approved messaging to ensure that only review-ready materials are uploaded into the enterprise CMS/DAM platform, including accurate references to facilitate claims linking, which minimizes costly, resource-wasting rounds of review. SecureCHEK AI shifts the reviewers’ focus by as much as 90% from tedious reverification to consideration of only what is different in derivative materials.
The ability to expedite approval of promotional materials displays the company’s direct contribution to enhancing the agility and responsiveness of marketing operations and content engagement teams.
Building the cornerstone for Generative AI
SecureCHEK AI recognizes that efficient data preparation is required to fill the content supply chain for Generative AI. SecureCHEK AI preps data by structuring credentialed content in a proprietary brand-specific database to ensure that sensitive information remains protected during AI queries and to enrich the pool of content available for brand building in the face of copyright restrictions.
SecureCHEK AI helps companies leverage the power of Generative AI with credible, substantiated, structured data for desired queries (e.g., summarization, Q&A, and generation of new content). Their software easily integrates with enterprise software solutions to amplify their impact by ensuring submitted materials are review-ready and enabling the GenAI promise in the face of challenging market factors.
New Product Launch Award: Tackling Laborious Tasks
The introduction of SecureCHEK AI’s ISI Verify and Label Updates tools in 2024 specifically addresses the laborious challenges associated with proofing Important Safety Information (text and format) and accelerating the required label updates in promotional materials to reflect FDA requirements. While an important advance no matter where the brand is in its lifecycle, this offering is particularly valuable during launch preparation for a new brand or indication, when the need for quick and accurate pull through of the final labeling across a high volume of materials can put enormous pressure on agency and client-side resources.
Diversity Award: Female Leadership Spearheading Innovation
SecureCHEK AI is owned and operated by a woman, which is particularly noteworthy in the traditionally male-dominated fields of technology and pharmaceuticals. The company’s CEO, Ilyssa Levins, has been a trailblazer in healthcare marketing and regulatory compliance, setting a powerful example for gender diversity in leadership. Ilyssa’s entrepreneurial spirit inspires other female professionals to be courageous and take bold steps.
“I had to wait years for AI to catch up with my vision of creating technology that would pre-check promotional content so that MLR could focus on priority issues. When AI became accessible to the public, I knew SecureCHEK AI would quickly be embraced—because it fills the business-critical unmet need for a more streamlined, accelerated, and less resource-heavy marketing and review process. This award affirms that my early efforts have paid off.” – Ilyssa Levins, CEO, SecureCHEK AI
Ilyssa Levins is responsible for a series of “firsts” in the pharmaceutical industry beginning with her career at a global healthcare marketing agency where she was intimately involved in review meetings and decisions. This led Ilyssa to launch the Center for Communication Compliance in 2008, an online training and certification company that helps marketers and their agencies effectively promote prescription drugs in compliance with government laws and policies. Seven years ago, Ilyssa created a prototype for her original idea to precheck materials prior to review and approval. Once AI became accessible to the public, Ilyssa decided to embark on her next venture culminating in the launch of SecureCHEK AI.
The Diversity award recognizes SecureCHEK AI’s dedication to creating an inclusive environment that values promoting women in leadership roles.
Company Profile
SecureCHEK® AI brings a whole new dimension to marketing by using the speed and accuracy of AI to automate business critical, repetitive, and labor-intensive tasks to get more promotional materials out faster. Launched in 2021, the company’s proprietary technology builds strong brands with two enabling pillars that help pharmaceutical manufacturers achieve and exceed marketing objectives:
1. Drives Efficiency: SecureCHEK AI accelerates creation and approval of promotional materials that meet MLR Review requirements to reduce unnecessary review cycles and avoid review bottlenecks
2. Fuels New, Original Content: SecureCHEK AI helps companies leverage the power of Gen AI by automatically mining credentialed, substantiated content and structuring the data collected to enable successful queries about the brand
The versatility and user-centric design of SecureCHEK AI’s offerings make them an indispensable asset for any forward-thinking pharmaceutical company.
Ilyssa Levins, CEO
Email Address: ilyssa@securechek.ai
Phone: 212-361-9868
Links:
